PortfoliosLab logoPortfoliosLab logo
RMD vs. INSP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

RMD vs. INSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ResMed Inc. (RMD) and Inspire Medical Systems, Inc. (INSP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RMD achieves a -11.95% return, which is significantly higher than INSP's -45.56% return.


RMD

1D
1.16%
1M
0.64%
6M
-17.89%
YTD
-11.95%
1Y
-23.69%
3Y*
-1.21%
5Y*
-4.10%
10Y*
13.03%
ALL TIME*
20.57%

INSP

1D
0.38%
1M
6.94%
6M
-33.74%
YTD
-45.56%
1Y
-60.18%
3Y*
-44.32%
5Y*
-22.80%
10Y*
ALL TIME*
9.10%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$40.00M$44.43M$52.50M
$221.77M$287.46M$300.95M

RMD vs. INSP - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
RMD
ResMed Inc.
-11.95%6.26%34.18%-16.55%-19.47%23.41%38.33%37.85%20.10%
INSP
Inspire Medical Systems, Inc.
-45.56%-50.25%-8.87%-19.24%9.48%22.31%153.46%75.64%72.52%

Correlation

The correlation between RMD and INSP is 0.36, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.36

Correlation (3Y)
Balances recent behavior with more history.

0.42

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.45

Correlation (All Time)
Calculated using the full available price history since May 3, 2018

0.41

Fundamentals

Market Cap

RMD:

$30.60B

INSP:

$1.45B

EPS

RMD:

$15.50

INSP:

$4.50

PE Ratio

RMD:

13.61

INSP:

11.17

PEG Ratio

RMD:

0.42

INSP:

0.06

PS Ratio

RMD:

3.73

INSP:

1.60

Total Revenue (TTM)

RMD:

$5.54B

INSP:

$915.25M

Gross Profit (TTM)

RMD:

$3.42B

INSP:

$785.06M

EBITDA (TTM)

RMD:

$2.10B

INSP:

$67.14M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RMD vs. INSP — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

RMD
RMD Risk / Return Rank: 1616
Overall Rank
RMD Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
RMD Sortino Ratio Rank: 1313
Sortino Ratio Rank
RMD Omega Ratio Rank: 1313
Omega Ratio Rank
RMD Calmar Ratio Rank: 2323
Calmar Ratio Rank
RMD Martin Ratio Rank: 2020
Martin Ratio Rank

INSP
INSP Risk / Return Rank: 1212
Overall Rank
INSP Sharpe Ratio Rank: 1010
Sharpe Ratio Rank
INSP Sortino Ratio Rank: 1111
Sortino Ratio Rank
INSP Omega Ratio Rank: 1010
Omega Ratio Rank
INSP Calmar Ratio Rank: 1111
Calmar Ratio Rank
INSP Martin Ratio Rank: 1616
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

RMD vs. INSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and Inspire Medical Systems, Inc. (INSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


RMDINSPDifference
Sharpe ratioReturn per unit of total volatility

0.00

Sortino ratioReturn per unit of downside risk

+0.08

Omega ratioGain probability vs. loss probability

0.88

0.85

+0.04

Calmar ratioReturn relative to maximum drawdown

-0.58

-0.83

+0.25

Martin ratioReturn relative to average drawdown

-1.08

-1.17

+0.08

RMD vs. INSP - Sharpe Ratio Comparison

The current RMD Sharpe Ratio is -0.79, which is comparable to the INSP Sharpe Ratio of -0.79. The chart below compares the historical Sharpe Ratios of RMD and INSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

RMD vs. INSP - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.61%, smaller than the maximum INSP drawdown of -87.72%. Use the drawdown chart below to compare losses from any high point for RMD and INSP.


Loading charts...

Drawdown Indicators


RMDINSPDifference

Max Drawdown

Largest peak-to-trough decline

-61.61%

-87.72%

+26.11%

Max Drawdown (1Y)

Largest decline over 1 year

-37.28%

-72.19%

+34.91%

Max Drawdown (3Y)

Largest decline over 3 years

-37.28%

-85.55%

+48.27%

Max Drawdown (5Y)

Largest decline over 5 years

-53.99%

-87.72%

+33.73%

Max Drawdown (10Y)

Largest decline over 10 years

-53.99%

Current Drawdown

Current decline from peak

-27.62%

-84.60%

+56.98%

Average Drawdown

Average peak-to-trough decline

-16.06%

-28.68%

+12.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.03%

51.14%

-31.11%

Volatility

RMD vs. INSP - Volatility Comparison

ResMed Inc. (RMD) and Inspire Medical Systems, Inc. (INSP) have volatilities of 12.95% and 13.40%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RMDINSPDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.95%

13.40%

-0.45%

Volatility (6M)

Calculated over the trailing 6-month period

23.18%

39.42%

-16.24%

Volatility (1Y)

Calculated over the trailing 1-year period

27.51%

75.49%

-47.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

31.52%

60.26%

-28.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

31.69%

60.30%

-28.61%

Dividends

RMD vs. INSP - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 1.14%, while INSP has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
INSP
Inspire Medical Systems, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
RMD
ResMed Inc.
1.14%0.94%0.88%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%

Financials

RMD vs. INSP - Financials Comparison

This section allows you to compare key financial metrics between ResMed Inc. and Inspire Medical Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

RMD vs. INSP - Profitability Comparison

The chart below illustrates the profitability comparison between ResMed Inc. and Inspire Medical Systems, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

RMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported a gross profit of 890.98M and revenue of 1.43B. Therefore, the gross margin over that period was 62.3%.

INSP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported a gross profit of 176.91M and revenue of 204.58M. Therefore, the gross margin over that period was 86.5%.

RMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported an operating income of 499.81M and revenue of 1.43B, resulting in an operating margin of 34.9%.

INSP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported an operating income of -1.12M and revenue of 204.58M, resulting in an operating margin of -0.6%.

RMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, ResMed Inc. reported a net income of 398.73M and revenue of 1.43B, resulting in a net margin of 27.9%.

INSP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Inspire Medical Systems, Inc. reported a net income of -11.29M and revenue of 204.58M, resulting in a net margin of -5.5%.


Frequently Asked Questions


RMD and INSP have a correlation of 0.36, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INSP has higher volatility (13.40%) compared to RMD (12.95%). In terms of maximum drawdown, RMD dropped -61.61% vs INSP's -87.72%.

RMD currently has the higher Sharpe Ratio (-0.79 vs -0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RMD and INSP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer